pathology group limited
pathology group limited Company Information
Company Number
05927809
Next Accounts
Sep 2025
Shareholders
icsg ltd
Group Structure
View All
Industry
Temporary employment agency activities
Registered Address
9 appold street, london, EC2A 2AP
pathology group limited Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY GROUP LIMITED at £2.1m based on a Turnover of £9.9m and 0.21x industry multiple (adjusted for size and gross margin).
pathology group limited Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY GROUP LIMITED at £1m based on an EBITDA of £267k and a 3.76x industry multiple (adjusted for size and gross margin).
pathology group limited Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY GROUP LIMITED at £3.4m based on Net Assets of £2.6m and 1.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pathology Group Limited Overview
Pathology Group Limited is a live company located in london, EC2A 2AP with a Companies House number of 05927809. It operates in the temporary employment agency activities sector, SIC Code 78200. Founded in September 2006, it's largest shareholder is icsg ltd with a 100% stake. Pathology Group Limited is a established, mid sized company, Pomanda has estimated its turnover at £9.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pathology Group Limited Health Check
Pomanda's financial health check has awarded Pathology Group Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £9.9m, make it smaller than the average company (£16.1m)
£9.9m - Pathology Group Limited
£16.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (5.9%)
14% - Pathology Group Limited
5.9% - Industry AVG
Production
with a gross margin of 19.5%, this company has a comparable cost of product (18.5%)
19.5% - Pathology Group Limited
18.5% - Industry AVG
Profitability
an operating margin of 2.7% make it as profitable than the average company (2.6%)
2.7% - Pathology Group Limited
2.6% - Industry AVG
Employees
with 18 employees, this is below the industry average (56)
- Pathology Group Limited
56 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Pathology Group Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £550.5k, this is more efficient (£247.2k)
- Pathology Group Limited
£247.2k - Industry AVG
Debtor Days
it gets paid by customers after 23 days, this is earlier than average (45 days)
23 days - Pathology Group Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 8 days, this is slower than average (4 days)
8 days - Pathology Group Limited
4 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pathology Group Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (6 weeks)
1 weeks - Pathology Group Limited
6 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 88.7%, this is a higher level of debt than the average (71.3%)
88.7% - Pathology Group Limited
71.3% - Industry AVG
PATHOLOGY GROUP LIMITED financials
Pathology Group Limited's latest turnover from December 2023 is £9.9 million and the company has net assets of £2.6 million. According to their latest financial statements, we estimate that Pathology Group Limited has 18 employees and maintains cash reserves of £464 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9,909,000 | 9,146,000 | 6,082,000 | 6,772,000 | 8,185,000 | 7,438,000 | 10,651,000 | 8,496,000 | 5,875,000 | 12,050,000 | 10,831,000 | 42,497,269 | 36,009,444 | 27,996,982 | 14,396,369 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 7,981,000 | 8,574,000 | 5,513,000 | 5,831,000 | 7,491,000 | 6,995,000 | 9,838,000 | 7,920,000 | 5,467,000 | 10,865,000 | 9,386,000 | 39,017,030 | 32,906,090 | 25,078,402 | 12,587,971 |
| Gross Profit | 1,928,000 | 572,000 | 569,000 | 941,000 | 694,000 | 443,000 | 813,000 | 576,000 | 408,000 | 1,185,000 | 1,445,000 | 3,480,239 | 3,103,354 | 2,918,580 | 1,808,398 |
| Admin Expenses | 1,661,000 | 1,056,000 | 661,000 | 1,021,000 | 267,000 | 500,000 | 32,000 | 532,000 | 2,889,000 | 839,000 | 487,000 | 1,445,603 | 1,451,113 | 900,718 | 682,451 |
| Operating Profit | 267,000 | -484,000 | -92,000 | -80,000 | 427,000 | -57,000 | 781,000 | 44,000 | -2,481,000 | 346,000 | 958,000 | 2,034,636 | 1,652,241 | 2,017,862 | 1,125,947 |
| Interest Payable | 48,000 | 102,611 | 142,170 | 138,004 | 122,815 | ||||||||||
| Interest Receivable | 934,000 | 452,000 | 2,251,000 | 18,000 | 12,000 | ||||||||||
| Pre-Tax Profit | 1,201,000 | -32,000 | -92,000 | 2,171,000 | 445,000 | -45,000 | 781,000 | 44,000 | -2,481,000 | 346,000 | 1,409,000 | 1,932,025 | 1,510,071 | 1,879,858 | 1,003,132 |
| Tax | -279,000 | 5,000 | -13,000 | -5,000 | 5,000 | 1,000 | 29,000 | 8,000 | 295,000 | -310,000 | -472,267 | -396,691 | -535,084 | -275,302 | |
| Profit After Tax | 922,000 | -32,000 | -87,000 | 2,158,000 | 440,000 | -40,000 | 782,000 | 73,000 | -2,473,000 | 641,000 | 1,099,000 | 1,459,758 | 1,113,380 | 1,344,774 | 727,830 |
| Dividends Paid | 2,226,000 | 450,000 | 597,200 | 312,918 | |||||||||||
| Retained Profit | 922,000 | -32,000 | -87,000 | 2,158,000 | 440,000 | -40,000 | 782,000 | 73,000 | -2,473,000 | 641,000 | -1,127,000 | 1,459,758 | 663,380 | 747,574 | 414,912 |
| Employee Costs | 2,453,000 | 3,505,000 | 3,825,000 | 4,172,000 | 3,870,000 | 3,899,000 | 1,814,000 | 1,650,000 | 3,205,065 | 2,496,164 | 1,383,735 | 516,739 | |||
| Number Of Employees | 50 | 70 | 84 | 94 | 96 | 100 | 43 | 26 | 62 | 50 | |||||
| EBITDA* | 267,000 | -483,000 | -89,000 | -72,000 | 445,000 | -31,000 | 851,000 | 178,000 | -2,314,000 | 450,000 | 1,087,000 | 2,068,624 | 1,683,982 | 2,028,149 | 1,128,323 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,000 | 3,000 | 9,000 | 24,000 | 38,000 | 84,000 | 190,000 | 242,000 | 209,000 | 74,046 | 56,620 | 32,452 | 7,131 | ||
| Intangible Assets | 1,000 | 3,000 | 5,000 | 7,000 | 2,000 | 3,000 | |||||||||
| Investments & Other | 15,000 | 15,000 | 15,000 | ||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 15,000 | 15,000 | 16,000 | 4,000 | 12,000 | 29,000 | 45,000 | 86,000 | 193,000 | 242,000 | 209,000 | 74,046 | 56,620 | 32,452 | 7,131 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 639,000 | 818,000 | 792,000 | 572,000 | 896,000 | 473,000 | 1,041,000 | 1,615,000 | 1,140,000 | 1,668,000 | 950,000 | 5,207,933 | 5,582,657 | 5,865,794 | 2,258,783 |
| Group Debtors | 21,660,000 | 18,721,000 | 15,219,000 | 10,539,000 | 12,332,000 | 13,939,000 | 10,660,000 | 11,721,000 | 10,997,000 | 7,220,000 | 2,666,000 | ||||
| Misc Debtors | 555,000 | 383,000 | 210,000 | 281,000 | 356,000 | 464,000 | 219,000 | 30,000 | 198,000 | 141,000 | 243,000 | 2,479,556 | 380,242 | 192,033 | 381,169 |
| Cash | 464,000 | 232,000 | 831,000 | 610,000 | 737,000 | 2,594,000 | 1,350,000 | 455,000 | 228,000 | 152,000 | 115,830 | 217,427 | 75,067 | 186,314 | |
| misc current assets | 28,000 | 23,000 | 22,000 | 883,000 | 230,000 | ||||||||||
| total current assets | 23,318,000 | 20,154,000 | 17,052,000 | 12,002,000 | 14,321,000 | 17,498,000 | 13,293,000 | 13,843,000 | 12,563,000 | 9,912,000 | 4,241,000 | 7,803,319 | 6,180,326 | 6,132,894 | 2,826,266 |
| total assets | 23,333,000 | 20,169,000 | 17,068,000 | 12,006,000 | 14,333,000 | 17,527,000 | 13,338,000 | 13,929,000 | 12,756,000 | 10,154,000 | 4,450,000 | 7,877,365 | 6,236,946 | 6,165,346 | 2,833,397 |
| Bank overdraft | 1,465,000 | 11,259 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 186,000 | 102,000 | 210,000 | 52,000 | 78,000 | 99,000 | 64,000 | 314,000 | 147,000 | 162,000 | 181,000 | 179,870 | 95,468 | 81,291 | 4,651 |
| Group/Directors Accounts | 19,220,000 | 16,963,000 | 14,381,000 | 9,407,000 | 13,851,000 | 17,504,000 | 13,167,000 | 14,108,000 | 13,516,000 | 7,017,000 | 3,436,000 | ||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,284,000 | 1,383,000 | 724,000 | 707,000 | 722,000 | 682,000 | 825,000 | 932,000 | 584,000 | 553,000 | 574,000 | 4,954,852 | 4,858,593 | 4,956,779 | 1,864,154 |
| total current liabilities | 20,690,000 | 18,448,000 | 15,315,000 | 10,166,000 | 14,651,000 | 18,285,000 | 14,056,000 | 15,354,000 | 14,247,000 | 9,197,000 | 4,191,000 | 5,134,722 | 4,954,061 | 5,038,070 | 1,880,064 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 75,000 | 82,000 | 57,000 | 7,771 | 1,402 | ||||||||||
| total long term liabilities | 75,000 | 82,000 | 57,000 | 7,771 | 1,402 | ||||||||||
| total liabilities | 20,690,000 | 18,448,000 | 15,315,000 | 10,166,000 | 14,651,000 | 18,285,000 | 14,056,000 | 15,429,000 | 14,329,000 | 9,254,000 | 4,191,000 | 5,134,722 | 4,954,061 | 5,045,841 | 1,881,466 |
| net assets | 2,643,000 | 1,721,000 | 1,753,000 | 1,840,000 | -318,000 | -758,000 | -718,000 | -1,500,000 | -1,573,000 | 900,000 | 259,000 | 2,742,643 | 1,282,885 | 1,119,505 | 951,931 |
| total shareholders funds | 2,643,000 | 1,721,000 | 1,753,000 | 1,840,000 | -318,000 | -758,000 | -718,000 | -1,500,000 | -1,573,000 | 900,000 | 259,000 | 2,742,643 | 1,282,885 | 1,119,505 | 951,931 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 267,000 | -484,000 | -92,000 | -80,000 | 427,000 | -57,000 | 781,000 | 44,000 | -2,481,000 | 346,000 | 958,000 | 2,034,636 | 1,652,241 | 2,017,862 | 1,125,947 |
| Depreciation | 1,000 | 2,000 | 6,000 | 16,000 | 24,000 | 67,000 | 133,000 | 167,000 | 104,000 | 129,000 | 33,988 | 31,741 | 10,287 | 2,376 | |
| Amortisation | 1,000 | 2,000 | 2,000 | 2,000 | 3,000 | 1,000 | |||||||||
| Tax | -279,000 | 5,000 | -13,000 | -5,000 | 5,000 | 1,000 | 29,000 | 8,000 | 295,000 | -310,000 | -472,267 | -396,691 | -535,084 | -275,302 | |
| Stock | |||||||||||||||
| Debtors | 2,932,000 | 3,701,000 | 4,829,000 | -2,192,000 | -1,292,000 | 2,956,000 | -1,446,000 | 1,031,000 | 3,306,000 | 5,170,000 | -3,828,489 | 1,724,590 | -94,928 | 3,417,875 | 2,639,952 |
| Creditors | 84,000 | -108,000 | 158,000 | -26,000 | -21,000 | 35,000 | -250,000 | 167,000 | -15,000 | -19,000 | 1,130 | 84,402 | 14,177 | 76,640 | 4,651 |
| Accruals and Deferred Income | -99,000 | 659,000 | 17,000 | -15,000 | 40,000 | -143,000 | -107,000 | 348,000 | 31,000 | -21,000 | -4,380,852 | 96,259 | -98,186 | 3,092,625 | 1,864,154 |
| Deferred Taxes & Provisions | -75,000 | -7,000 | 25,000 | 57,000 | -7,771 | 6,369 | 1,402 | ||||||||
| Cash flow from operations | -2,959,000 | -3,633,000 | -4,738,000 | 2,066,000 | 1,751,000 | -3,090,000 | 1,866,000 | -316,000 | -5,571,000 | -4,408,000 | 225,767 | 52,428 | 1,290,439 | 1,250,824 | 83,276 |
| Investing Activities | |||||||||||||||
| capital expenditure | -51,414 | -45,909 | -35,608 | ||||||||||||
| Change in Investments | 15,000 | ||||||||||||||
| cash flow from investments | -51,414 | -45,909 | -35,608 | ||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 2,257,000 | 2,582,000 | 4,974,000 | -4,444,000 | -3,653,000 | 4,337,000 | -941,000 | 592,000 | 6,499,000 | 3,581,000 | 3,436,000 | ||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 934,000 | 452,000 | 2,251,000 | 18,000 | 12,000 | -48,000 | -102,611 | -142,170 | -138,004 | -122,815 | |||||
| cash flow from financing | 3,191,000 | 3,034,000 | 4,974,000 | -2,193,000 | -3,635,000 | 4,349,000 | -941,000 | 592,000 | 6,499,000 | 3,581,000 | 2,031,357 | -102,611 | -642,170 | -718,004 | 414,204 |
| cash and cash equivalents | |||||||||||||||
| cash | 232,000 | -599,000 | 221,000 | -127,000 | -1,857,000 | 1,244,000 | 895,000 | 227,000 | 228,000 | -152,000 | 36,170 | -101,597 | 142,360 | -111,247 | 186,314 |
| overdraft | -1,465,000 | 1,465,000 | -11,259 | 11,259 | |||||||||||
| change in cash | 232,000 | -599,000 | 221,000 | -127,000 | -1,857,000 | 1,244,000 | 895,000 | 227,000 | 1,693,000 | -1,617,000 | 36,170 | -101,597 | 142,360 | -99,988 | 175,055 |
pathology group limited Credit Report and Business Information
Pathology Group Limited Competitor Analysis
Perform a competitor analysis for pathology group limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other mid companies, companies in EC2A area or any other competitors across 12 key performance metrics.
pathology group limited Ownership
PATHOLOGY GROUP LIMITED group structure
Pathology Group Limited has 10 subsidiary companies.
Ultimate parent company
ACACIUM GROUP HOLDINGS LTD
#0131674
2 parents
PATHOLOGY GROUP LIMITED
05927809
10 subsidiaries
pathology group limited directors
Pathology Group Limited currently has 2 directors. The longest serving directors include Mr Thomas Richards (Jul 2017) and Mr Michael Barnard (Jun 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Thomas Richards | United Kingdom | 47 years | Jul 2017 | - | Director |
| Mr Michael Barnard | England | 52 years | Jun 2019 | - | Director |
P&L
December 2023turnover
9.9m
+8%
operating profit
267k
-155%
gross margin
19.5%
+211.11%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2.6m
+0.54%
total assets
23.3m
+0.16%
cash
464k
+1%
net assets
Total assets minus all liabilities
pathology group limited company details
company number
05927809
Type
Private limited with Share Capital
industry
78200 - Temporary employment agency activities
incorporation date
September 2006
age
19
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
N/A
accountant
DELOITTE LLP
auditor
-
address
9 appold street, london, EC2A 2AP
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
pathology group limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to pathology group limited. Currently there are 1 open charges and 6 have been satisfied in the past.
pathology group limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PATHOLOGY GROUP LIMITED. This can take several minutes, an email will notify you when this has completed.
pathology group limited Companies House Filings - See Documents
| date | description | view/download |
|---|
